Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment
The current data suggested that race did not have a major impact on survival in patients with PCa who deferred primary treatment for clinically nonmetastatic disease.
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency